Trial Profile
Evaluation of HLA-B 5701 screening prior to abacavir administration for prevention of the hypersensitivity reaction.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Sep 2021
Price :
$35
*
At a glance
- Drugs Abacavir (Primary)
- Indications HIV infections; Hypersensitivity
- Focus Adverse reactions; Pharmacogenomic
- 06 Sep 2021 Status changed from recruiting to completed.
- 10 Feb 2010 New trial record